Skip to main content
Fig. 5 | Biomaterials Research

Fig. 5

From: Design of chimeric GLP-1A using oligomeric bile acids to utilize transporter-mediated endocytosis for oral delivery

Fig. 5

In vivo oral absorption of GLP-1A-Cys and oligomeric DOCA-G1As. A Time course of GLP-1A concentration after treatment with intravenous GLP-1A-Cys (10 μg/kg, n = 4), oral GLP-1A-Cys (100 μg/kg, n = 4), and B oral oligomeric DOCA-G1As (100 μg/kg, n = 4). Data are presented as mean ± standard deviation. **p < 0.01 and ***p < 0.001 compared with GLP-1A-Cys

Back to article page

Biomaterials Research

ISSN: 2055-7124

Contact us